Federal contract award
75H71025P00585
REVERSE PHARMACEUTICAL DISTRIBUTION SERVICES THAT COLLECT AND PROCESS UNWANTED, UNUSABLE, OR OUTDATED PHARMACEUTICALS FOR RETURN TO THE DRUG MANUFACTURE FOR CREDIT OR DISPOSAL IN ACCORDANCE WITH ALL APPLICABLE REGULATIONS RELATED TO PHARMACEUTICAL AN
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NAVAJO AREA INDIAN HEALTH SVC |
| NAICS | 541614 — Process, Physical Distribution, and Logistics Consulting Services |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $21.6K |
| Current contract value | $21.6K |
| Potential contract value / ceiling | $64.8K |
| Start date | Apr 8, 2025 |
| Current end date | Mar 31, 2027 |
| Potential end date | Mar 31, 2030 |
| Latest award activity | May 14, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 14, 2026 | P00002 | $10.8K | REVERSE PHARMACEUTICAL DISTRIBUTION SERVICES THAT COLLECT AND PROCESS UNWANTED, UNUSABLE, OR OUTDATED PHARMACEUTICALS FOR RETURN TO THE DRUG MANUFACTURE FOR CREDIT OR DISPOSAL IN ACCORDANCE WITH ALL APPLICABLE REGULATIONS RELATED TO PHARMACEUTICAL AN |
| Mar 31, 2026 | P00001 | $0 | REVERSE PHARMACEUTICAL DISTRIBUTION SERVICES THAT COLLECT AND PROCESS UNWANTED, UNUSABLE, OR OUTDATED PHARMACEUTICALS FOR RETURN TO THE DRUG MANUFACTURE FOR CREDIT OR DISPOSAL IN ACCORDANCE WITH ALL APPLICABLE REGULATIONS RELATED TO PHARMACEUTICAL AN |
| Apr 8, 2025 | 0 | $10.8K | REVERSE PHARMACEUTICAL DISTRIBUTION SERVICES THAT COLLECT AND PROCESS UNWANTED, UNUSABLE, OR OUTDATED PHARMACEUTICALS FOR RETURN TO THE DRUG MANUFACTURE FOR CREDIT OR DISPOSAL IN ACCORDANCE WITH ALL APPLICABLE REGULATIONS RELATED TO PHARMACEUTICAL AN |
Estimated positioning window
Mar 31, 2029 – Sep 30, 2029
30/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 30/100. Available recorded signals: 25 points.
- Contract end 2030-03-31 (1253 days from calculation)
- +5 points
- 1 historical awards in this buyer and category group
- +0 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2026-05-14
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Marshall Arviso | Contact | Marshall.Arviso@ihs.gov 5057866319 | Source | Mar 7, 2025 |
| Janice Martinez | Contact | Janice.Martinez@ihs.gov 5057866216 | Source | Mar 7, 2025 |
| Marshall Arviso | Contact | Marshall.Arviso@ihs.gov 5057866319 | Source | Feb 11, 2025 |
| Janice Martinez | Contact | Janice.Martinez@ihs.gov 5057866216 | Source | Feb 11, 2025 |
| Marshall Arviso | Contact | Marshall.Arviso@ihs.gov 5057866319 | Source | Feb 11, 2025 |
| Janice Martinez | Contact | Janice.Martinez@ihs.gov 5057866216 | Source | Feb 11, 2025 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.